A city filled with passion

Article

If passion could cure breast cancer, it would be a thing of the past. The more than 7,500 attendees at this year's SABCS have brought a lot of passion to San Antonio this week. You only have to listen to the video from Debu Tripathy, M.D., our Editor-in-Chief, about hormone therapy trials delivered today to know that the researchers are eager for any news that will help them save the lives of their patients. Their passion is matched by the advocates, the breast cancer survivors and family who are here, whether they represent a group, a type of cancer or themselves because they want to know more to have an impact on some aspect of breast cancer. Take Betty Sommer from Houston. She is here because her daughter Stacey can't be. Stacey died in 2010 from triple negative breast cancer at age 39, so Betty, 64, an at-home travel agent, decided she would come for Stacey and learn everything she could about triple negative breast cancer. Betty looked around for other mothers when she got here, but didn't see any. "Where are they?" she asked. "Two weeks after I buried Stacey, I was volunteering." That was in February 2010, and now Betty has started her own nonprofit Causes for a Cure that is dedicated to raising money for cancer research. Stacey Gaecke, Betty's daughter, died exactly one year after she was diagnosed. An elementary teacher who loved the "little ones" as her mom calls them, Stacey had two sons of her own who were 10 and 12 at the time. She was the light of her mother's life.Betty still can't believe how fast the cancer took her daughter. Diagnosed in February, she finished treatment in October and told all her friends she was clear of cancer. Both her doctor and her mother suggested she stay away from that kind of language since the chances of recurrence had been high from diagnosis with 11 positive nodes. They were proved true so soon. On Christmas eve Stacey learned her cancer was back in multiple nodes and her liver was already very involved. What Betty has already learned from doing the advanced Project Lead offered as part of the Alamo Breast Cancer Foundation advocacy program, is that what she thought was one disease now appears to have seven subsets. Raising funds for cancer research has become her passionate focus now. The golf tournament that helped Stacey's family last year is now helping another family through Betty's nonprofit. And Betty is looking for that place that she will make a difference near her home in Houston. She has money and energy to give and when the connection is right, she will help find answers to triple negative breast cancer. She is doing it because Stacey would have.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content